DRDO's 2-DG drug being developed for brain tumour patients initially but recently they transformed it for COVID treatment: Dr Anil Mishra

<span style="color: #222222;">Scientists of Defence Research and Development Organisation DRDO's research wing Institute of Nuclear medicine and applied sciences have recently developed a life saving drug for COVID patients named 2 DG. The drug helps the serious patients in recovery and will also stop the spread of infection further. It will also decrease the need of medical oxygen in such patients. In a special interview with All India Radio News Dr. Anil Kumar Mishra, Director, Institute of Nuclear medicine and applied sciences explained how the drug works on any patient and saves life.</span><br />” <span style="color: #222222;">&nbsp;</span><br />” <span style="color: #222222;">Dr. Mishra also said that this drug was being developed for brain tumour patients initially but recently they transformed it for&nbsp;COVID&nbsp;treatment.&nbsp;</span><br />” &nbsp;<br />

Most Read
View All arrow-right

No posts found.